Aerie Pharmaceuticals Inc (AERI)

In this article, we discuss 10 best-performing small-cap stocks of 2022. O’Shaughnessy Asset Management demonstrated the relative outperformance of smaller and cheaper stocks over the long-term.

In this article, we will discuss how hedge funds were right about these 10 small-cap stocks. With the threat of a global recession looming over their heads, investors are having a tough time in 2022.

While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, increasing oil prices and deteriorating expectations towards the resolution of the trade...

Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged during the first quarter.

It was a rough fourth quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 4.8% during 2018 and average hedge fund losing...

With the threat of severe drug pricing regulations behind it for now, the biotech sector has launched a rally in recent days, with the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) gaining over...

Biotechnology is a very interesting industry to invest in, but also very complex.

Equities have opened sharply lower today as investors remain cautious ahead of the Federal Reserve’s monetary policy meeting next week.

Despite the relatively small change in the major indexes on Wednesday, many investors are on edge in anticipation of the Federal Reserve FOMC meeting later this month.